These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1164777)

  • 1. Inclusion complexes of beta-cyclodextrin with antiinflammatory drugs fenamates in aqueous solution.
    Ikeda K; Uekama K; Otagiri M
    Chem Pharm Bull (Tokyo); 1975 Jan; 23(1):201-8. PubMed ID: 1164777
    [No Abstract]   [Full Text] [Related]  

  • 2. Inclusion complexes of beta-cyclodextrin with tranquilizing drugs phenothiazines in aqueous solution.
    Otagiri M; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1975 Jan; 23(1):188-95. PubMed ID: 240508
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of alpha- and beta-cyclodextrin with several non-steroidal antiinflammatory drugs in aqueous solution.
    Hamada Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1205-11. PubMed ID: 241500
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of inclusion of nonsteroidal antiinflammatory drugs with beta-cyclodextrin on the irritation to stomach of rats upon oral administration.
    Nambu N; Kikuchi K; Kikuchi T; Takahashi Y; Ueda H; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Dec; 26(12):3609-12. PubMed ID: 747846
    [No Abstract]   [Full Text] [Related]  

  • 5. Inclusion complexation of barbiturates with beta-cyclodextrin in aqueous solution. I. Spectroscopic study on the mode of interaction.
    Otagiri M; Miyaji T; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1146-54. PubMed ID: 1021280
    [No Abstract]   [Full Text] [Related]  

  • 6. Inclusion compounds of non-steroidal antiinflammatory and other slightly water soluble drugs with alpha- and beta-cyclodextrins in powdered form.
    Kurozumi M; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1975 Dec; 23(12):3062-8. PubMed ID: 1218446
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Circular dichroism study on inclusion complexes of beta-cyclodextrin with anti-inflammatory fanamates.
    Ikeda K; Uekama K; Otagiri M; Hatano M
    J Pharm Sci; 1974 Jul; 63(7):1168-9. PubMed ID: 4852725
    [No Abstract]   [Full Text] [Related]  

  • 8. Utilization of cyclodextrin complexation for separation of E, A, and B prostaglandins by ion-exchange liquid chromatography.
    Uekama K; Hirayama F; Ikeda K; Inaba K
    J Pharm Sci; 1977 May; 66(5):706-10. PubMed ID: 874756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
    Miyajima K; Yokoi M; Komatsu H; Nakagaki M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous determination of complexation equilibrium constants for conjugated guest species by extended potentiometric titration method: on barbiturate-beta-cyclodextrin system.
    Miyaji T; Kurono Y; Uekama K; Ikeda K
    Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1155-9. PubMed ID: 1021281
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of beta-cyclodextrin on the degradation rate of cinnarizine in aqueous solution.
    Tokumura T; Tatsuishi K; Kayano M; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2079-83. PubMed ID: 4053231
    [No Abstract]   [Full Text] [Related]  

  • 13. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
    Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
    [No Abstract]   [Full Text] [Related]  

  • 14. Inclusion complexes of ploy-beta-cyclodextrin: a model for pressure effects upon ligand-protein complexes.
    Torgerson PM; Drickamer HG; Weber G
    Biochemistry; 1979 Jul; 18(14):3079-83. PubMed ID: 465455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of pharmaceuticals with Schardinger dextrins. VI. Interactions of beta-cyclodextrin, sodium deoxycholate, and deoxycholic acid with amines and pharmaceutical agents.
    Lach JL; Pauli WA
    J Pharm Sci; 1966 Jan; 55(1):32-8. PubMed ID: 5918647
    [No Abstract]   [Full Text] [Related]  

  • 17. Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes.
    Armstrong DW; Ward TJ; Armstrong RD; Beesley TE
    Science; 1986 May; 232(4754):1132-5. PubMed ID: 3704640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of powdered inclusion compounds of nonsteroidal antiinflammatory drugs with beta-cyclodextrin in rabbits and dogs.
    Nambu N; Shimoda M; Takahashi Y; Ueda H; Nagai T
    Chem Pharm Bull (Tokyo); 1978 Oct; 26(10):2952-6. PubMed ID: 729102
    [No Abstract]   [Full Text] [Related]  

  • 19. Rescue from hypervitaminosis A or potentiation of retinoid toxicity by different modes of cyclodextrin administration.
    Pitha J; Szente L
    Life Sci; 1983 Feb; 32(7):719-23. PubMed ID: 6827906
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the interaction of clobazam with cyclodextrins in solution and in the solid state.
    Nakai Y; el-Said Aboutaleb A; Yamamoto K; Saleh SI; Ahmed MO
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):728-32. PubMed ID: 2347015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.